Hoang V. T. auteur aut IRD Goumballa N. auteur aut IRD Dao T. L. auteur aut IRD Ly T. D. A. auteur aut IRD Ninove L. auteur aut IRD Ranque S. auteur aut IRD Raoult D. auteur aut IRD Parola P. auteur aut IRD Sokhna Cheikh auteur aut IRD de Santi V. P. auteur aut IRD Gautret P. auteur aut IRD text journalArticle eng text/pdf born digital access Background: The Grand Magal of Touba is the largest Muslim pilgrimage in Senegal with a potential for infectious disease transmission. Methods: Clinical follow-up, adherence to preventive measures and qPCR-based respiratory and gastrointestinal pathogens carriage pre- and post-Magal, were assessed. Results: 110 pilgrims from South Senegal were included. The duration of stay in Touba was 3 days. 41.8% and 14.5% pilgrims reported respiratory and gastrointestinal symptoms. Most individuals having the onset of symptoms during their stay in Touba, or soon after returning. The acquisition of rhinoviruses, coronaviruses and adenovirus was 13.0, 16.7 and 4.6% respectively and that of Streptococcus pneumoniae and Haemophilus influenzae was 3.7% and 26.9%. Acquisition of gastrointestinal viruses and parasites was low, while bacterial acquisition ranged from 2.2% for Campylobacter jejuni to 33.0% for enteropathogenic Escherichia coli. Conclusion: This preliminary study confirms that Grand Magal pilgrims are likely to be exposed to communicable disease risk as observed in other pilgrimage settings. Further study including larger numbers of pilgrims are needed to investigate potential risk factors for respiratory and gastrointestinal infections at the Grand Magal. specialized Respiratory tract infections Gastrointestinal infection PCR Grand magal Touba Pilgrims SENEGAL TOUBA 050 052 32 art. 101410 [7 ] 2019 1477-8939 https://www.documentation.ird.fr/hor/fdi:010077449 10.1016/j.tmaid.2019.04.010 1477-8939 [F B010077449] https://www.documentation.ird.fr/hor/fdi:010077449 https://www.documentation.ird.fr/intranet/publi/2020/01/010077449.pdf Accès réservé (Intranet de l'IRD) IRD - Base Horizon / Pleins textes 2020-02-05 2025-09-22 fdi:010077449 fre